US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 53.910
- +0.180+0.34%
Close Apr 26 16:00 ET
- 54.110
- +0.200+0.37%
Post 19:59 ET
4.58BMarket Cap-27788P/E (TTM)
54.935High52.814Low1.35MVolume54.210Open53.730Pre Close73.21MTurnover1.62%Turnover RatioLossP/E (Static)84.88MShares91.10052wk High2.43P/B4.49BFloat Cap37.55052wk Low--Dividend TTM83.37MShs Float220.200Historical High--Div YieldTTM3.95%Amplitude11.630Historical Low54.087Avg Price1Lot Size
CRISPR Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 47.48%-260.38M | 15.23%-96.07M | 62.12%-39.86M | 6.14%-133.25M | 106.51%8.8M | -191.98%-495.74M | -31.72%-113.33M | -29.37%-105.22M | -117.59%-141.96M | -34.35%-135.24M |
| Net income from continuing operations | 76.37%-153.61M | 180.80%89.35M | 35.75%-112.15M | 58.17%-77.74M | 70.39%-53.07M | -272.16%-650.18M | 21.72%-110.58M | -37.27%-174.55M | -124.48%-185.83M | -58.37%-179.22M |
| Depreciation and amortization | -17.93%19.84M | -16.18%4.9M | -1.85%4.93M | -31.75%4.96M | -16.36%5.05M | 34.64%24.17M | -6.63%5.85M | -5.75%5.02M | 98.99%7.27M | 122.43%6.04M |
| Other non cash items | -212.63%-14.05M | -2,276.26%-4.77M | -299.96%-5.16M | -188.21%-3.15M | -115.89%-969K | -11.62%12.47M | -95.33%219K | -48.43%2.58M | 51.81%3.57M | 195.49%6.1M |
| Change In working capital | -1,075.49%-193.59M | -545.02%-203.97M | 41.34%52.56M | -1,066.16%-79.08M | 505.53%36.91M | -26.11%19.85M | -271.01%-31.62M | 299.96%37.19M | -39.10%8.19M | 142.41%6.1M |
| -Change in receivables | -65,673.77%-200M | -408,263.27%-200M | 411,664.71%70M | -91,009.09%-70M | --0 | 289.44%305K | 132.03%49K | 950.00%17K | --77K | 2,800.00%162K |
| -Change in prepaid assets | 1,353.00%23.22M | 218.05%6.45M | -83.76%817K | 251.69%3.91M | 161.11%12.04M | 111.49%1.6M | -212.36%-5.46M | 154.06%5.03M | 41.41%-2.58M | 190.98%4.61M |
| -Change in payables and accrued expense | -492.08%-20.25M | 70.44%-9.19M | -188.32%-24.69M | -216.72%-11.58M | 1,660.27%25.21M | -86.23%5.16M | -236.50%-31.1M | 2,040.74%27.96M | -48.33%9.92M | 71.99%-1.62M |
| -Change in other current liabilities | 107.23%110K | 7.80%705K | 89.29%-110K | 68.31%-315K | -10.39%-170K | 71.33%-1.52M | -44.48%654K | -67.54%-1.03M | 52.76%-994K | 95.91%-154K |
| -Change in other working capital | -76.69%3.33M | -145.76%-1.94M | 25.68%6.55M | -162.43%-1.1M | -105.72%-177K | 63.92%14.3M | 141.61%4.24M | -70.91%5.21M | 135.25%1.76M | 1,193.72%3.09M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 47.48%-260.38M | 15.23%-96.07M | 62.12%-39.86M | 6.14%-133.25M | 106.51%8.8M | -191.98%-495.74M | -31.72%-113.33M | -29.37%-105.22M | -117.59%-141.96M | -34.35%-135.24M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 244.84%374.65M | 53.60%-81.45M | 38.74%121.35M | 486.87%216.92M | 202.89%117.83M | 75.02%-258.66M | -1,913.91%-175.53M | 115.48%87.46M | 80.90%-56.07M | 31.79%-114.52M |
| Net PPE purchase and sale | 74.53%-9.47M | 88.08%-738K | 64.80%-2.12M | 63.08%-3.56M | 80.07%-3.06M | 54.49%-37.19M | 32.58%-6.19M | 83.76%-6.02M | 66.15%-9.63M | -118.54%-15.35M |
| Net intangibles purchase and sale | ---2.5M | --0 | ---1M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | 274.57%386.62M | 52.34%-80.72M | 33.15%124.47M | 577.97%221.98M | 221.91%120.89M | 76.78%-221.47M | -36,361.46%-169.34M | 117.70%93.48M | 82.49%-46.44M | 38.36%-99.17M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 244.84%374.65M | 53.60%-81.45M | 38.74%121.35M | 486.87%216.92M | 202.89%117.83M | 75.02%-258.66M | -1,913.91%-175.53M | 115.48%87.46M | 80.90%-56.07M | 31.79%-114.52M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 62.38%62.66M | 1,471.39%38.94M | -89.70%1.56M | 61.93%16.77M | -49.25%5.4M | -84.62%38.59M | -60.66%2.48M | 47.98%15.11M | 22.62%10.35M | -95.29%10.65M |
| Net common stock issuance | 3,273.30%32.72M | --32.72M | ---- | ---- | ---- | -99.55%970K | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -20.41%29.94M | 150.93%6.22M | -89.00%1.56M | 61.93%16.77M | -49.25%5.4M | -0.15%37.62M | -60.66%2.48M | 38.48%14.14M | 5.99%10.35M | -6.58%10.65M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 62.38%62.66M | 1,471.39%38.94M | -89.70%1.56M | 61.93%16.77M | -49.25%5.4M | -84.62%38.59M | -60.66%2.48M | 47.98%15.11M | 22.62%10.35M | -95.29%10.65M |
| Net cash flow | ||||||||||
| Beginning cash position | -76.16%224.06M | 5.74%539.6M | -11.01%456.6M | -49.18%356.12M | -76.16%224.06M | -20.71%939.94M | -50.38%510.33M | -69.18%513.07M | -38.68%700.81M | -20.71%939.94M |
| Current changes in cash | 124.72%176.94M | 51.61%-138.59M | 3,243.38%83.05M | 153.52%100.44M | 155.22%132.03M | -191.55%-715.8M | -223.76%-286.38M | 99.58%-2.64M | -135.97%-187.68M | -461.67%-239.11M |
| Effect of exchange rate changes | 191.25%73K | -46.96%61K | 52.00%-48K | 141.18%28K | 218.52%32K | -627.27%-80K | 3,733.33%115K | -316.67%-100K | -1,460.00%-68K | -640.00%-27K |
| End cash Position | 79.00%401.07M | 79.00%401.07M | 5.74%539.6M | -11.01%456.6M | -49.18%356.12M | -76.16%224.06M | -76.16%224.06M | -50.38%510.33M | -69.18%513.07M | -38.68%700.81M |
| Free cash flow | 48.90%-272.35M | 19.00%-96.81M | 61.37%-42.97M | 8.76%-138.3M | 103.81%5.74M | -216.55%-532.93M | -25.52%-119.52M | 6.03%-111.24M | -119.47%-151.59M | -39.84%-150.59M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
